Day 1 - Oxford Debate: Should Pharma Stop Visiting HCPs?

NEXT Pharma Summit 172 viewsMore from this channel

Watch the NEXT 26 Session: "Oxford Debate: Should Pharma Stop Visiting HCPs?", with our industry leader: ▪️ Andrew Binns - Director at Poke ▪️Yacin Marzouki - Founder | independent pharma advisor at Biond health Explore all sessions of the NEXT 2026 Vienna here - • NEXT CX & AI 26 Vienna - Main Stage Make sure you subscribe to the @NEXTPharmaSummit YouTube channel. Follow us on: Facebook: / nextpharmasummit Instagram: / nextpharmasummit LinkedIn: / next-pharma-summit #nextpharmasummit #thenextlive #NEXT26 #pharmaconference #patientengagement #hcp #healthcare #patientengagement #pharmaceuticalconcept #digital #CXM #pharma #customerengagement #customerexperience #omnichannel #digitaltransformation #medicalaffairs #medaffairs #aiinhealthcare #pharmatech #medtech #healthcaretrends #pharmaleaders #futureofpharma #healthtech #pharmacommunity

Day 1 - Oxford Debate: Should Pharma Stop Visiting HCPs?

Suggested videos

Aftermovie - NEXT Pharma Summit 2026 Dubrovnik 💜

Cut Through the Noise: Creating Meaningful Pharma Content | NEXT Pharma Summit 2023

Day 1 - The Reality of Personalisation: Can Pharma Really Deliver at Scale?

Day 1 -The Rep Paradox. Why AI Makes Every HCP Conversation More Valuable—and More Vulnerable

DAY 1 -Pharma, Your Brand Isn’t the Hero – Your Customer Is

Day 1 - Pharma’s Future Commercial Leader, Builder, Orchestrator or AI Manager?

Day 2 - Disrupting Pharma’s Customer Engagement Model